Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density

Cell Transplantation

Volumn 20, Issue 9, 2011, Pages 1409-1422

  Cholewa, Dominik ^a   Stieh, Thomas ^b,c   Schellenberg, Anne ^a   Bokermann, Gudrun ^a   Joussen, Sylvia ^a   Koch, Carmen ^a   Walenda, Thomas ^a   Pallua, Norbert ^d   Marciniak Czochra, Anna ^b,c   Suschek, Christoph V ^d   Wagner, Wolfgang ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c HEIDELBERG ACADEMY OF SCIENCES AND HUMANITIES   (Germany)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Adipose tissue; Cellular automaton model; Human platelet lysate (HPL); Mesenchymal stromal cells (MSCs); Plating density

Indexed keywords

ADIPOSE TISSUE; ADULT; ARTICLE; CELL DENSITY; CELL DIVISION; CELL EXPANSION; CELL LYSATE; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL SUBPOPULATION; COMPUTER SIMULATION; CONTROLLED STUDY; FEMALE; FETAL CALF SERUM; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MESENCHYMAL STROMAL CELL; MODEL; PRIORITY JOURNAL; STROMA CELL; THROMBOCYTE;

ADIPOSE TISSUE; BLOOD PLATELETS; CELL AGING; CELL COUNT; CELL EXTRACTS; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; CELLS, CULTURED; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; SERUM; TIME FACTORS;

EID: 80855150910     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X557218     Document Type: Article

References (46)

1. Avanzini M. A.; Bernardo M. E.; Cometa A. M.; Perotti C.; Zaffaroni N.; Novara F.; Visai L.; Moretta A.; Del, Fante C.; Villa R.; Ball L. M.; Fibbe W. E.; Maccario R.; Locatelli F. Generation of mesenchymal stromal cells in the presence of platelet lysate: A phenotypic and functional comparison of umbilical cord blood-and bone marrow-derived progenitors. Haematologica 94:1649-1660; 2009.
2. Baer P. C.; Griesche N.; Luttmann W.; Schubert R.; Luttmann A.; Geiger H. Human adipose-derived mesenchymal stem cells in vitro: Evaluation of an optimal expansion medium preserving stemness. Cytotherapy 12:96-106; 2010.
3. Banfi A.; Muraglia A.; Dozin B.; Mastrogiacomo M.; Cancedda R.; Quarto R. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp. Hematol. 28:707-715; 2000.
4. Bartmann C.; Rohde E.; Schallmoser K.; Purstner P.; Lanzer G.; Linkesch W.; Strunk D. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion 47:1426-1435; 2007.
5. Bieback K.; Hecker A.; Kocaomer A.; Lannert H.; Schallmoser K.; Strunk D.; Kluter H. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27:2331-2341; 2009.
6. Blande I. S.; Bassaneze V.; Lavini-Ramos C.; Fae K. C.; Kalil J.; Miyakawa A. A.; Schettert I. T.; Krieger J. E. Adipose tissue mesenchymal stem cell expansion in animal serum-free medium supplemented with autologous human platelet lysate. Transfusion 49:2680-2685; 2009.
7. Bonab M. M.; Alimoghaddam K.; Talebian F.; Ghaffari S. H.; Ghavamzadeh A.; Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 7:14; 2006.
8. Bork S.; Pfister S.; Witt H.; Horn P.; Korn B.; Ho A. D.; Wagner W. DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell 9:54-63; 2010.
9. Both S. K.; van der Muijsenberg A. J.; van Blitterswijk C. A.; de Boer J.; de Bruijn J. D. A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng. 13:3-9; 2007.
10. Carrancio S.; Lopez-Holgado N.; Sanchez-Guijo F. M.; Villaron E.; Barbado V.; Tabera S.; Diez-Campelo M.; Blanco J.; San Miguel J. F.; Del Canizo M. C. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp. Hematol. 36:1014-1021; 2008.
11. Colter D. C.; Class R.; DiGirolamo C. M.; Prockop D. J. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc. Natl. Acad. Sci. USA 97:3213-3218; 2000.
12. Colter D. C.; Sekiya I.; Prockop D. J. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc. Natl. Acad. Sci. USA 98:7841-7845; 2001.
13. Cristofalo V. J.; Allen R. G.; Pignolo R. J.; Martin B. G.; Beck J. C. Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc. Natl. Acad. Sci. USA 95:10614-10619; 1998.
14. Debacq-Chainiaux F.; Erusalimsky J. D.; Campisi J.; Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat. Protoc. 4:1798-1806; 2009.
15. De Francesco F.; Tirino V.; Desiderio V.; Ferraro G.; D'Andrea F.; Giuliano M.; Libondi G.; Pirozzi G.; De Rosa A.; Papaccio G. Human CD34/CD90 ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLoS One 4:e6537; 2009.
16. Dimri G. P.; Lee X.; Basile G.; Acosta M.; Scott G.; Roskelley C.; Medrano E. E.; Linskens M.; Rubelj I.; Pereira-Smith O.; Peacocke M.; Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363-9367; 1995.
17. Dominici M.; Le Blanc K.; Mueller I.; Slaper-Cortenbach I.; Marini F.; Krause D.; Deans R.; Keating A.; Prockop D.; Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006.
18. Doucet C.; Ernou I.; Zhang Y.; Llense J. R.; Begot L.; Holy X.; Lataillade J. J. Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell-based therapy applications. J. Cell. Physiol. 205:228-236; 2005.
19. Furlani D.; Li W.; Pittermann E.; Klopsch C.; Wang L.; Knopp A.; Jungebluth P.; Thedinga E.; Havenstein C.; Westien I.; Ugurlucan M.; Li R. K.; Ma N.; Steinhoff G. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant. 18:319-331; 2009.
20. Griesche N.; Luttmann W.; Luttmann A.; Stammermann T.; Geiger H.; Baer P. C. A simple modification of the separation method reduces heterogeneity of adipose-derived stem cells. Cells Tissues Organs 192:106-115; 2010.
21. Heiskanen A.; Satomaa T.; Tiitinen S.; Laitinen A.; Mannelin S.; Impola U.; Mikkola M.; Olsson C.; Miller-Podraza H.; Blomqvist M.; Olonen A.; Salo H.; Lehenkari P.; Tuuri T.; Otonkoski T.; Natunen J.; Saarinen J.; Laine J. N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells 25:197-202; 2007.
22. Holzwarth C.; Vaegler M.; Gieseke F.; Pfister S. M.; Handgretinger R.; Kerst G.; Muller I. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells. BMC Cell Biol. 11:11; 2010.
23. Horn P.; Bokermann G.; Cholewa D.; Bork S.; Walenda T.; Koch C.; Drescher W.; Hutschenreuther G.; Zenke M.; Ho A.; Wagner W. Comparison of individual platelet lysates for isolation of human mesenchymal stromal cells. Cytotherapy 12:888-898; 2010.
24. Horn P.; Bork S.; Diehlmann A.; Walenda T.; Eckstein V.; Ho A. D.; Wagner W. Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis. Cytotherapy 10:676-685; 2008.
25. Jiang Y.; Vaessen B.; Lenvik T.; Blackstad M.; Reyes M.; Verfaillie C. M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp. Hematol. 30:896-904; 2002.
26. Lee Y.; Kouvroukoglou S.; McIntire L. V.; Zygourakis K. A cellular automaton model for the proliferation of migrating contact-inhibited cells. Biophys. J. 69:1284-1298; 1995.
27. Lepperdinger G.; Brunauer R.; Jamnig A.; Laschober G.; Kassem M. Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies? Exp. Gerontol 43:1018-1023; 2008.
28. Lund P.; Pilgaard L.; Duroux M.; Fink T.; Zachar V. Effect of growth media and serum replacements on the proliferation and differentiation of adipose-derived stem cells. Cytotherapy 11:189-197; 2009.
29. Marciniak-Czochra A.; Stiehl T.; Wagner W. Modeling of replicative senescence in hematopoietic development. Aging 1:723-732; 2009.
30. Muller I.; Kordowich S.; Holzwarth C.; Spano C.; Isensee G.; Staiber A.; Viebahn S.; Gieseke F.; Langer H.; Gawaz M. P.; Horwitz E. M.; Conte P.; Handgretinger R.; Dominici M. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM. Cytotherapy 8:437-444; 2006.
31. Neuhuber B.; Swanger S. A.; Howard L.; Mackay A.; Fischer I. Effects of plating density and culture time on bone marrow stromal cell characteristics. Exp. Hematol. 36:1176-1185; 2008.
32. Neuss S.; Stainforth R.; Salber J.; Schenck P.; Bovi M.; Knuchel R.; Perez-Bouza A. Long-term survival and bipotent terminal differentiation of human mesenchymal stem cells (hMSC) in combination with a commercially available three-dimensional collagen scaffold. Cell Transplant. 17:977-986; 2008.
33. Noer A.; Boquest A. C.; Collas P. Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol. 8:18; 2007.
34. Quirici N.; Scavullo C.; de Girolamo L.; Lopa S.; Arrigoni E.; Deliliers G. L.; Brini A. T. Anti-L-NGFR and -CD34 Monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Stem Cells Dev. 19:915-925; 2010.
35. Schallmoser K.; Bartmann C.; Rohde E.; Reinisch A.; Kashofer K.; Stadelmeyer E.; Drexler C.; Lanzer G.; Linkesch W.; Strunk D. Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47:1436-1446; 2007.
36. Schneider E. L.; Mitsui Y. The relationship between in vitro cellular aging and in vivo human age. Proc. Natl. Acad. Sci. USA 73:3584-3588; 1976.
37. Sekiya I.; Larson B. L.; Smith J. R.; Pochampally R.; Cui J. G.; Prockop D. J. Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells 20:530-541; 2002.
38. Shay J. W.; Wright W. E. Hayflick, his limit, and cellular ageing. Nat. Rev. Mol. Cell Biol. 1:72-76; 2000.
39. Stenderup K.; Justesen J.; Clausen C.; Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33:919-926; 2003.
40. Sundin M.; Ringden O.; Sundberg B.; Nava S.; Gotherstrom C.; Le Blanc K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92:1208-1215; 2007.
41. Wagner W.; Bork S.; Lepperdinger G.; Joussen S.; Ma N.; Strunk D.; Koch C. How to track cellular aging of mesenchymal stromal cells. Aging 2:224-230; 2010.
42. Wagner W.; Ho A. D. Mesenchymal stem cell preparations-comparing apples and oranges. Stem Cell Rev. 3:239-248; 2007.
43. Wagner W.; Ho A. D.; Zenke M. Different facets of aging in human mesenchymal stem cells. Tissue Eng. Part B Rev. 16:445-453; 2010.
44. Wagner W.; Horn P.; Castoldi M.; Diehlmann A.; Bork S.; Saffrich R.; Benes V.; Blake J.; Pfister S.; Eckstein V.; Ho A. D. Replicative senescence of mesenchymal stem cells-a continuous and organized process. PLoS One 3:e2213; 2008.
45. Zhou S.; Greenberger J. S.; Epperly M. W.; Goff J. P.; Adler C.; Leboff M. S.; Glowacki J. Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts. Aging Cell 7:335-343; 2008.
46. Zygourakis K.; Bizios R.; Markenscoff P. Proliferation of anchorage-dependent contact-inhibited cells: I. Development of theoretical models based on cellular automata. Biotechnol. Bioeng. 38:459-470; 1991.